Active Pharmaceutical Ingredients (APIs)

  • Tenofovir Alafenamide*

    • API Product   :   

      Tenofovir Alafenamide*

    • CEP   :   

      -

    • WCC   :   

      -

    • Therapeutic Use    :   

      Antivirals for systemic use

    • Originator   :   

      Gilead Sciences

    • CAS No.    :   

      379270-37-8

    • Trade Name.   :   

      VIREAD

    • Molecular Weight   :   

      476.466 g/mol

    • Molecular Formula   :   

      C21H29N6O5P

    Application

    Tenofovir alafenamide is used to treat chronic hepatitis B infection, a viral infection of the liver. It works by stopping or slowing the growth of the virus. Chronic hepatitis infection can lead to serious liver damage (cirrhosis) and liver cancer.

    General Description

    Tenofovir disoproxil, sold under the trade name Viread among others, is a medication used to treat chronic hepatitis B and to prevent and treat HIV/AIDS.[1] It is generally recommended for use with other antiretrovirals.[1] It may be used for prevention of HIV/AIDS among those at high risk before exposure, and after a needlestick injury or other potential exposure.[1] It is sold both by itself and together as emtricitabine/tenofovir and efavirenz/emtricitabine/tenofovir.[1] It does not cure HIV/AIDS or hepatitis B.[1][2] It is available by mouth as a tablet or powder.[1] Common side effects include nausea, rash, diarrhea, headache, pain, depression, and weakness.[1] Severe side effects include high blood lactate and an enlarged liver.[1] There are no absolute contraindications.[1] It is often recommended during pregnancy and appears to be safe.[1] It is a nucleotide reverse transcriptase inhibitor and works by decreasing the ability of the viruses to replicate.